Status:
COMPLETED
Feasibility Study for Ultrasound-Guided Interstitial Brachytherapy for Gynecological CancersV2
Lead Sponsor:
Western University, Canada
Conditions:
Gynecologic Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Brachytherapy treatment in gynecological cancers is an essential component to delivering adequate doses of radiation to a tumour while sparing normal tissue. Interstitial and intracavitary brachythera...
Detailed Description
This is an efficacy study to optimize the use of three-dimensional ultrasound imaging for interstitial and intracavitary brachytherapy. In this study, 3DUS images will be acquired during the regular c...
Eligibility Criteria
Inclusion
- Patients with locally advanced or recurrent gynecological malignancies who are offered interstitial or intracavitary brachytherapy treatment. These typically would include patients with primary or recurrent vaginal cancers, endometrial cancers or cervical cancers. Histologies of these cancers are typically adenocarcinomas or squamous cell carcinomas
Exclusion
- Above patients who are not offered interstitial or intracavitary brachytherapy as a treatment modality
Key Trial Info
Start Date :
February 17 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 7 2022
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04336683
Start Date
February 17 2015
End Date
April 7 2022
Last Update
May 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Regional Cancer Program, Victoria Hospital
London, Ontario, Canada, N6A 5W9